ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 302991 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 302991; 2) Community: the network communities that were significantly associated with the response to NSC 302991; 3) Molecule: the relationships between components within communities and NSC 302991; 4) MDR: the compounds that were significantly associated with the NSC 302991.

NSC Compound Enrichment Correlation
NSC 94037 Mikanolide 0.0312262198176281 -0.044024601
NSC 111533 Methoxycamptothecin 0.0312262198176283 0.66614734
NSC 625544 Null 0.0352383000003052 0.21458153
NSC 626162 Discorhabdin C . TFA 0.0352383000003052 0.11584522
NSC 674276 Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- 0.0352383000003052 0.10649005
NSC 759016 Null 0.0352383000003052 0.16513467
NSC 100880 Camptothecin 0.0352383000003056 0.85396173
NSC 135687 5.beta.-Bufa-20,22-dienolide, 14,15.beta.-epoxy-3.beta.,5-dihydroxy-, 3-acetate (8CI) 0.0352383000003056 0.30463112
NSC 185065 Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- 0.0352383000003056 0.10318925
NSC 18805 .gamma.-Thujaplicine 0.0352383000003056 0.27460932
Total:45  Current:27    [First] [Prev] [Next] [Last]